Patients' confidence with colorectal cancer screening procedures is predictive of their likelihood to schedule and follow through with screening.
Transportation issues, lack of awareness, other barriers may be to blame for diminished colorectal screening rates.
Novel diagnostic test determines whether suspicious lung lesions or nodules are malignant disease from a sample obtained via nasal swab.
Survey data from patients receiving care at Boston Medical Center who were navigated for colonoscopy screening illustrates how patients value the services of oncology patient navigators.
Researchers report on their evaluation of the impact of the 2012 USPSTF recommendation on volumes of prostate biopsy and radical prostatectomy.
A new colorectal cancer (CRC) screening test that can be done in the privacy of patients' homes, at their convenience, and with no prep needed may help patients overcome their reticence.
Population-based screening for breast cancer with universal biennial mammography resulted in a substantial reduction in breast cancer deaths, while risk-based biennial mammography resulted in only a modest benefit.
Women with symptoms of serious mental illness are significantly less likely to receive routine cancer screening.
Analysis of the gut microbiome more successfully distinguished healthy persons from those with precancerous adenomatous polyps and those with invasive colorectal cancer compared with assessment of clinical risk factors and fecal occult blood testing, according to recently published data.
Mammography-detected breast cancer is associated with a shift to earlier stage diagnosis in older women, subsequently reducing the rate of more advanced, difficult-to-treat cases. Researchers said the findings lend support to regular mammography screening in women age 75 years and older.
Anxiety regarding inconclusive cancer screening test results among some patients is real and is only natural. However, as evidenced by a recent study, the incidence and effects of anxiety associated with false positive or other results of CT lung cancer screening exams are far less than claimed by some in the medical community.
A new study of participants in the NLST found evidence that men and women age 55 to 74 who had an abnormal finding on a lung cancer screening test did not experience more anxiety or reduced quality of life than did those who were screened and found to be cancer-free.
Underserved Latina patients view interactive voice response (IVR) messages as an acceptable strategy to promote cancer screening, according to a study.
Longer withdrawal times during a colonoscopy correlate with a higher rate of polyp detection, according to new research.
Primary screening for HPV provides 60% to 70% greater protection against invasive cervical cancer than the cytology-based (smear test) screening currently used.
For people with a family history of adenomas, up to 10% of colorectal cancers could be missed when current national screening guidelines are followed.
A survey finds that most patients are not being told about the possibility of overdiagnosis and overtreatment as a result of cancer screenings.
Many people caring for a family member with dementia want to put an end to screening the person for cancer as the dementia progresses, and are relieved when health care providers bring up the topic, according to the findings of a small focus-group study.
A new streamlined method rapidly identifies genetic changes in small protein fragments unique to melanoma cancer cells.
Centers in the United States can achieve a 20% reduction in lung cancer mortality with low-dose computed tomography (LDCT) versus chest X-ray (CXR) screening that was previously reported by the National Lung Screening Trial (NLST).
A new genomic approach for screening compounds has identified a compound that causes neuroblastoma cells to differentiate. This new strategy screens for compounds that could inhibit tumor growth by causing cancer cells to differentiate.
Exposure to Agent Orange has been linked to lethal forms of prostate cancer among US veterans by a new analysis.
Pioneering biophotonics technology is the first screening method to detect the early presence of ovarian cancer in humans
High-quality CT colonoscopy diagnostic images can be maintained while reducing the radiation dose, according to a new study.
The digital rectal examination is an important screening test that can discover prostate cancer that a PSA test may not, despite the higher sensitivity of the PSA test.
A new immunoassay that tests for the presence of three biomarkers appears to be a valid screening method for the early detection of malignant kidney cancer. The immunoassay measured the levels of three potential biomarkers for kidney cancer.
A new study adds support to current medical recommendations stating that screening colonoscopy substantially reduced the likelihood of advanced CRC in either the right or left side of the colon being diagnosed in an average-risk adult.
Researchers used electronic EHRs to identify patients in a health care cooperative who were not screened regularly for cancer of the colon and rectum, and to encourage them to be screened.
A pilot study of the PapGene test, which relies on genomic sequencing of cancer-specific mutations, accurately detected all 24 (100%) endometrial cancers and nine of 22 (41%) ovarian cancers.
Cancer survivors meet U.S. Healthy People 2010 goals for all screening except cervical cancer.
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Cancer Risk Not Increased by Childhood Exposure to Diagnostic Radiation
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Immune Thrombocytopenia (Fact Sheet)
- Novel 3D Marker Reduces Radiation, Improves Cosmesis in Breast Conserving Surgery
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|